Bio-engineering much stronger immune systems
Vancouver BC: Scientists at Network Immunology Inc. have successfully combined components from multiple immune systems, to form a more stable,
and fundamentally stronger, immune system.
The resultant, patented immuno-therapeutic product, AbstimX™ has been shown to substantially increase resistance to breast cancer, autoimmunity/inflammation,
and allergic disease in mouse studies.
The technology is based on the Nobel Prize winning immune network theory, which has been developed by Nobel Laureate, Dr. Niels Kaj Jerne,
Dr. Geoffrey W. Hoffmann, and Reginald Gorczynski, MD, PhD.
Network Immunology Inc. is a privately held biotech company that develops immuno-therapeutics based on immune network theory.
CSO Geoffrey W. Hoffman Explains Immune Network Theory.
CEO George Hoffman discusses Network Immunology's latest research breakthrough in organ transplantation.
Toronto, ON: Network Immunology has received breakthrough data for its platform Co-selection Technology™ that has potential applications to transplantation, autoimmunity and other degenerati..